Feedback

Browsing by A

Use an asterisk (*) for partial word searches (e.g. pemph*)

273 results found.

1.
Ordering Recommendation:  

Monitor postprandial hyperglycemia and short-term glycemic control when hemoglobin A1c is 6.1-7.9%.

2.
3.
4.
5.
6.
7.
Ordering Recommendation:  

Detect Acanthamoeba spp and Naegleria fowleri in various specimen types.

8.
Ordering Recommendation:  

Detect Acanthamoeba spp, Naegleria spp, and other free-living amoebae.

9.
10.
11.
12.
Ordering Recommendation:  

Monitor exposure to acetone.

13.
14.
Ordering Recommendation:  

Acceptable reflexive panel for diagnosing myasthenia gravis. Panel contains binding, blocking, and modulating antibodies; titin antibody; and striated muscle antibodies with reflex to titer.

15.
Ordering Recommendation:  

Preferred reflexive panel for diagnosing myasthenia gravis. Panel contains binding, blocking, and modulating antibodies.

16.
Ordering Recommendation:  

Initial diagnostic testing for myasthenia gravis. For reflexive panel, which contains binding, blocking, and modulating antibodies, refer to Acetylcholine Receptor Antibody Reflexive Panel (2001571).

17.
Ordering Recommendation:  

Initial diagnostic testing for myasthenia gravis. For reflexive panel, which contains binding, blocking, and modulating antibodies, refer to Acetylcholine Receptor Antibody Reflexive Panel (2001571).

18.
Ordering Recommendation:  

Assessment of clinical activity of and initial diagnostic testing for myasthenia gravis. For reflexive panel, which contains binding, blocking, and modulating antibodies, refer to Acetylcholine Receptor Antibody Reflexive Panel (2001571).

19.
Ordering Recommendation:  

Use following an abnormal amniotic fluid alpha fetoprotein (AFP) result to evaluate possibility of a fetal open neural tube defect.

20.
Ordering Recommendation:  

Confirm clinical or suspected diagnosis of achondroplasia.

21.
Ordering Recommendation:  

Confirm diagnosis in at-risk fetus or those with ultrasonographic features consistent with achondroplasia.

22.
Ordering Recommendation:  

Use to detect aerobic actinomycetes (Nocardia and Gordonia spp, etc) in clinical specimens.

23.
Ordering Recommendation:  

Total acid phosphatase (AP) activity may be useful when evaluating for prostate cancer, Paget's disease, hyperparathyroidism with skeletal involvement, and Gaucher's disease since elevations in AP activity occur in these conditions.

24.
Ordering Recommendation:  

Gold standard test for diagnosing the presence of mycobacteria organisms.

25.
Ordering Recommendation:  

Comprehensive panel includes acid-fast bacillus culture and stain; positive smears reflex to PCR amplification of M. tuberculosis complex species and rifampin resistance.

26.
Ordering Recommendation:  

Identification of acid-fast organisms (AFB) isolated in pure culture.

27.
Ordering Recommendation:  

Order for complete IDENTIFICATION and SUSCEPTIBILITY of clinically significant isolates of M. tuberculosis complex (MTBC), M. kansasii, M. avium-intracellulare complex, M. fortuitum complex, M. abscessus complex, M. chelonae, M. immunogenum, and any isolate from a significant source.

28.
Ordering Recommendation:  

Monitor respiratory specimens in previously diagnosed patients. Should NOT be ordered without culture in previously undiagnosed patients. For panel test that includes culture and stain, refer to Acid-Fast Bacillus (AFB) Culture and AFB Stain (0060152).

29.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

30.
Ordering Recommendation:  

Recommended FISH panel for adults with newly diagnosed ALL.

31.
Ordering Recommendation:  

Recommended FISH panel for children with newly diagnosed ALL.

32.
Ordering Recommendation:  

Use in conjunction with conventional cytogenetics for diagnosis, prognosis, and monitoring of minimal residual disease (MRD) in therapy-related MDS or AML associated with MDS. Use to establish and/or monitor for abnormal clone.

33.
Ordering Recommendation:  

Identify prognostically important abnormalities in newly diagnosed AML. Monitor response to therapy with specific probes (CHR FISHI) or progression of disease with probe panel.

34.
35.
Ordering Recommendation:  

Diagnose and monitor for fatty acid oxidation disorders and organic acidemias. Use in conjunction with urine organic acids and acylglycines testing.

36.
Ordering Recommendation:  

Diagnose and monitor for fatty acid oxidation disorders and organic acidemias. Use in conjunction with urine organic acids and plasma acylcarnitines testing.

37.
Ordering Recommendation:  

Evaluate response failure to adalimumab therapy. Determine and adjust dosage or identify the need for change to another anti-TNF-α inhibitor.

38.
Ordering Recommendation:  

Evaluate response failure to adalimumab therapy. Determine and adjust dosage or identify the need for change to another anti-TNF-α inhibitor.

39.
Ordering Recommendation:  

Assist in diagnosing congenital or inherited thrombotic thrombocytopenic purpura (TTP).

40.
Ordering Recommendation:  

Evaluate tuberculous meningitis.

41.
Ordering Recommendation:  

Evaluate tuberculous pericarditis.

42.
Ordering Recommendation:  

Evaluate tuberculous peritonitis.

43.
Ordering Recommendation:  

Evaluate tuberculous pleuritis.

44.
Ordering Recommendation:  

May be used as a marker of severe combined immunodeficiency (SCID); lack of adenosine deaminase (ADA) allows deoxyadenosine to accumulate and kill lymphocytes.

45.
Ordering Recommendation:  

Diagnose adenovirus-associated gastroenteritis.

46.
Ordering Recommendation:  

Not recommended for diagnosis of active adenovirus infection. Direct detection of virus is recommended (culture, DFA, PCR, or antigen detection as clinically indicated by suspected site of infection).

47.
Ordering Recommendation:  

Aids in histologic diagnosis of adenovirus.

48.
Ordering Recommendation:  

Detect adenovirus groups A-F.

49.
Ordering Recommendation:  

Detect and quantify adenovirus groups A-F.

50.
51.
Ordering Recommendation:  

• Detect accumulation of specific steroids as a result of enzyme deficiencies in congenital adrenal hyperplasia (CAH).
• Monitor patients with CAH.

52.
Ordering Recommendation:  

Aids in the diagnosis of adrenal insufficiency and determining the presence of anterior pituitary tumors.

53.
Ordering Recommendation:  

Screen, diagnose, and monitor diseases associated with excess or deficient cortisol production.

54.
Ordering Recommendation:  

Screen, diagnose, and monitor diseases associated with excess or deficient cortisol production.

55.
Ordering Recommendation:  

Screen, diagnose, and monitor diseases associated with excess or deficient cortisol production.

56.
Ordering Recommendation:  

Confirm a diagnosis of X-linked Adrenoleukodystrophy following abnormal biochemical testing or determine carrier status in females. Detects most pathogenic mutations.

57.
Ordering Recommendation:  

This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787 x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.

58.
Ordering Recommendation:  

Recommended test to confirm a diagnosis of X-linked Adrenoleukodystrophy following abnormal biochemical testing or to determine carrier status in females.

59.
Ordering Recommendation:  

Identify aerobic bacterial isolates. For suspected agents of bioterrorism, notify state department of health and refer isolates to state laboratory for identification. Susceptibilities on agents of bioterrorism are not performed at ARUP. For identification by 16s rDNA sequencing only, refer to Organism Identification by 16s rDNA Sequencing (0060720). For identification AND susceptibility testing, refer to Aerobic Organism Identification with Reflex to Susceptibility (0065070).

60.
Ordering Recommendation:  

Reflex panel to identify aerobic bacterial isolate and  determine in vitro susceptibility to antimicrobial agents.

61.
Ordering Recommendation:  

Preferred test for individuals with clinical phenotype of agammaglobulinemia.

62.
Ordering Recommendation:  

Aid in the diagnosis of aggressive large B-cell lymphoma with intermediate features between Burkitt lymphoma and diffuse large B-cell lymphoma (DLBCL) and confirmation of suspected double-hit lymphoma.

63.
Ordering Recommendation:  

Refer to Additional Technical Information document.

64.
65.
Ordering Recommendation:  

May assist in assessing nutritional status or in indicating a possible chronic process.

66.
Ordering Recommendation:  

Aids in discriminating transudate from exudate in the evaluation of ascites.

67.
Ordering Recommendation:  

Aids in diagnosis of multiple sclerosis.

68.
69.
Ordering Recommendation:  

Limited utility in the assessment of acute ethanol exposure. For the assessment of ethanol exposure up to several days post-exposure, Ethyl Glucuronide Screen with Reflex to Confirmation, Urine (2007912) is preferred.

70.
Ordering Recommendation:  

Use to identify ethanol, methanol, isopropanol or acetone ingestion.

71.
Ordering Recommendation:  

Do not use as a stand-alone test. This non-specific test has been replaced by more specific markers for muscle or liver damage. It has largely been replaced by other enzyme tests such as CK, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) as markers of muscle or liver damage.

72.
Ordering Recommendation:  

Use in aldosterone suppression or loading testing.

73.
Ordering Recommendation:  

Use in aldosterone suppression or stimulation testing.

74.
Ordering Recommendation:  

Diagnose and screen for primary hyperaldosteronism.

75.
Ordering Recommendation:  

The combined aldosterone/renin tests are preferred (refer to Aldosterone/Renin Activity Ratio (0070073) or Aldosterone and Renin, Direct with Ratio (2002582)) for diagnosing hyperaldosteronism.

76.
Ordering Recommendation:  

For screening and diagnosing for primary hyperaldosteronism, order this urine test concurrently with the serum renin testing (refer to Renin Activity (0070105)).

77.
Ordering Recommendation:  

Diagnose and screen for primary hyperaldosteronism.

78.
Ordering Recommendation:  

Detects ALK fusion proteins (IHC) and ALK gene rearrangements (FISH) in solid tumors.

79.
Ordering Recommendation:  

Determine eligibility for tyrosine kinase inhibitor (TKI) therapy, primarily in individuals with pulmonary adenocarcinomas. Test detects ALK fusion proteins.

80.
Ordering Recommendation:  

Screening test for all ALK fusions. Use this test especially if the companion diagnostic test for crizotinib is required.

81.
Ordering Recommendation:  

Alkaline phosphatase may be increased in the CSF of patients with intracranial germ cell tumors. When increased, isoenzyme testing can identify if a heat-stable isoenzyme (ie, germ cell or placental) is present but cannot quantify the amount of activity.

82.
Ordering Recommendation:  

Use when total alkaline phosphatase activity is elevated to determine amounts contributed by bone and liver isoenzymes.

83.
84.
85.
Ordering Recommendation:  

Evaluate possibility of a fetal open neural tube defect at 13-36 weeks of gestation.

86.
87.
Ordering Recommendation:  

Surveillance and monitoring in hepatocellular carcinoma; test is less specific than one which includes AFP-L3 isoform.

88.
Ordering Recommendation:  

Surveillance and monitoring of hepatocellular carcinoma.

89.
Ordering Recommendation:  

Preferred first-tier genetic test for confirmation of suspected alpha thalassemia or alpha thalassemia trait. Assesses for common, rare, and novel deletions or duplications in the alpha globin gene cluster.

90.
Ordering Recommendation:  

Second-tier genetic test for detection of alpha thalassemia or alpha thalassemia trait. REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial screening test is deletion/duplication (2011622).

91.
Ordering Recommendation:  

Comprehensive genetic test for detection of alpha thalassemia or alpha thalassemia trait.

92.
Ordering Recommendation:  

May be useful for monitoring certain pituitary tumors.

93.
Ordering Recommendation:  

Acceptable first-tier genetic test for confirmation of suspected alpha thalassemia or alpha thalassemia trait. Assesses for seven common alpha globin gene deletions.

94.
Ordering Recommendation:  

Limited clinical use.

95.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

96.
Ordering Recommendation:  

Determines alpha-1-antitrypsin (AAT) enzyme plasma concentration for the initial evaluation of AAT deficiency.

97.
Ordering Recommendation:  

Aids in histologic diagnosis of Alpha-1-Antitrypsin deficiency.

98.
Ordering Recommendation:  

Preferred test to identifiy alpha-1-antitrypsin deficiency and causative DNA and protein variants.

99.
100.
Ordering Recommendation:  

Determine specific AAT protein variant(s) in individual with decreased concentration of AAT (<90mg/dL).

101.
102.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

103.
Ordering Recommendation:  

Aids in diagnosis of proximal tubule injury and/or impaired proximal tubular function.

104.
Ordering Recommendation:  

• Screen for alpha-2-antiplasmin deficiency.
• Not a first-line test for diagnosing inherited thrombotic or bleeding disorders.

105.
Ordering Recommendation:  

May be used as a marker of membrane permeability in urine or as an indirect marker for liver fibrosis.

106.
Ordering Recommendation:  

Enzyme testing is reliable for diagnosing Fabry disease in males; it does not detect carriers. For carrier status, DNA analysis is recommended.

107.
Ordering Recommendation:  

Use to diagnose patients for mucopolysaccharidosis type I (also known as MPS I, Hurler, Scheie, and Hurler-Scheie syndromes). To screen for all types of MPS, refer to Mucopolysaccharides Screen - Electrophoresis & Quantitation, Urine (0081352). To monitor glycosaminoglycans (GAGs) in patients previously diagnosed with MPS, refer to Mucopolysaccharides, Quantitative, Urine (0081357).

108.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

109.
Ordering Recommendation:  

This is a second tier test and REQUIRES PERMISSION from  ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.

110.
Ordering Recommendation:  

Acceptable first-line genetic test for the detection of mutations causing X-linked Alport syndrome. 

111.
Ordering Recommendation:  

Diagnostic testing for X-linked Alport syndrome. Carrier screening for X-linked Alport syndrome. Predictive testing for X-linked Alport syndrome. 

112.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

113.
Ordering Recommendation:  

Serum aluminum may be useful in the assessment of aluminum toxicity due to dialysis and is the preferred test for routine screening. For chronic exposure, aluminum in urine (0099408) is preferred.

114.
Ordering Recommendation:  

Urine aluminum may be useful for monitoring aluminum exposure and is preferred in the assessment of chronic exposure. For aluminum toxicity due to dialysis or for routine screening, serum aluminum (0099266) is preferred.

115.
116.
117.
118.
119.
Ordering Recommendation:  

Aid in the diagnosis of selected neurotransmitter disorders (eg, glycine encephalopathy, brain serine deficiency).

120.
Ordering Recommendation:  

Diagnose and monitor aminoacidopathies (eg, PKU, MSUD).

121.
Ordering Recommendation:  

Screen for disorders of amino acids transport (eg, cystinuria, lysinuric protein intolerance, HHH syndrome).  Also useful to evaluate renal tubular function.

122.
Ordering Recommendation:  

Evaluate suspected aminolevulinic acid dehydratase deficiency (ADP) porphyria or hereditary tyrosinemia.

123.
Ordering Recommendation:  

Evaluate suspected aminolevulinic acid dehydratase deficiency (ADP) porphyria or hereditary tyrosinemia.

124.
Ordering Recommendation:  

Confirm a diagnosis of aminolevulinic acid dehydratase deficiency porphyria (ADP), an extremely rare porphyria.

125.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

126.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

127.
128.
Ordering Recommendation:  

Assess alloimmune hemolytic disease of the fetus. Follow progression of disease to determine need for fetal transfusion or early delivery. Evaluate in conjunction with fetal Rh genotyping.

129.
130.
Ordering Recommendation:  

Detect Acanthamoeba spp, Naegleria fowleri and other free-living amoebae.

131.
132.
Ordering Recommendation:  

May be used to distinguish between compliance or abuse of amphetamine-containing compounds. For general screening of amphetamines, Amphetamines Urine Screen with Reflex to Quantitation (2012209) is preferred.

133.
Ordering Recommendation:  

Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out amphetamine exposure. For follow-up testing of a presumptive result, Amphetamines, Urine Quantitative (2010075) is preferred.

134.
Ordering Recommendation:  

Detect exposure to amphetamines.

135.
Ordering Recommendation:  

Preferred test to follow-up presumptive results. For general screening, Amphetamines Urine Screen with Reflex to Quantitation (2012209) is preferred.

136.
Ordering Recommendation:  

Consider ordering in individuals with stiff-person syndrome, paraneoplastic encephalomyelitis (PEM), and sensory neuronopathy (SN). May aid in diagnosis of occult tumor, recurrence of tumor, or second tumor.

137.
Ordering Recommendation:  

Refer to aruplab.com/bodyfluids for clinical indications and interpretive information.

138.
139.
140.
141.
Ordering Recommendation:  

Use to confirm the clinical diagnosis of amyotrophic lateral sclerosis (ALS).

142.
Ordering Recommendation:  

May be used to detect anabolic steroid abuse.

143.
Ordering Recommendation:  

Diagnose anaerobic bacterial infections.

144.
Ordering Recommendation:  

Identify cultured anerobe organism. For identification by 16s rDNA sequencing only, refer to Organism Identification by 16s rDNA Sequencing (0060720). For identification AND susceptibility testing, refer to Anaerobic Organism Identification with Reflex to Susceptibility (0060198).

145.
Ordering Recommendation:  

Reflex panel to identify anaerobic bacterial isolate and determine in vitro susceptibility to antimicrobial agents. Refer to NOTE section below for list of antimicrobial agents available for testing.

146.
Ordering Recommendation:  

Acceptable test for acute or convalescent phase of infection from Anaplasma phagocytophilium. May be useful when PCR testing is not an option (eg, outside the 2 week window for acute phase). However, PCR testing is generally preferred; refer to Tick-Borne Disease Panel by PCR, Blood (2008670) or Ehrlichia and Anaplasma Species by Real-Time PCR (2007862).

147.
148.
Ordering Recommendation:  

Most useful to detect antibodies during acute phase of disease; recommend concurrent testing with IgG A. phagocyophilium. PCR testing is preferred; refer to Tick-Borne Disease Panel by PCR, Blood (2008670) or Ehrlichia and Anaplasma Species by Real-Time PCR (2007862).

149.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

150.
Ordering Recommendation:  

• Preferred reflex panel for the workup of suspected vasculitis. Panel detects ANCA, MPO, and PR-3 antibodies.
• For patients with a history of vasculitis, refer to the ANCA panel that reflexes to a titer, testing for MPO and PR-3 antibodies (2002068).  Individual antibody tests are available; refer to Serine Protease 3 Antibody (0050527) or Myeloperoxidase Antibody (0050526) tests.

151.
Ordering Recommendation:  

Not generally recommended. Adjunct tool for the evaluation of hirsutism.

152.
Ordering Recommendation:  

Aids in the investigation of virilizing endocrinopathies and in managing congenital adrenal hyperplasia in conjunction with other sex steroids. Not recommended for initial evaluation of polycystic ovarian syndrome.

153.
154.
Ordering Recommendation:  

Second tier test for the diagnosis of Angelman syndrome. Order if suspicion for Angelman syndrome remains after normal methylation analysis. For first-tier testing, refer to Angelman Syndrome and Prader-Willi Syndrome by Methylation (2005077).

155.
Ordering Recommendation:  

Preferred initial diagnostic test for Angelman syndrome or Prader-Willi syndrome.

156.
Ordering Recommendation:  

Prenatal testing for Angelman syndrome or Prader-Willi syndrome. Identifies cases resulting from molecular mechanisms that produce abnormal methylation patterns.

157.
Ordering Recommendation:  

Support diagnosis of neurosarcoidosis. May be used to evaluate treatment response.

158.
159.
160.
Ordering Recommendation:  

May assist in the diagnosis of ankylosing spondylitis. This test is not diagnostic for ankylosing spondylitis and is only suggestive of the condition if there are other clinical signs and symptoms. Test should not be performed for prenatal diagnosis of ankylosing spondylitis since a positive result is not predictive for the disorder.

161.
Ordering Recommendation:  

Assess risk for lupus nephritis and global systemic lupus erythematosus (SLE) disease activity.

162.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

163.
Ordering Recommendation:  

Use prior to transfusion or in possible transfusion reactions to determine the presence of anti-IgA antibodies in patients with selective IgA deficiency.

164.
165.
Ordering Recommendation:  

• Preferred reflex panel for managing patients with a known diagnosis of vasculitis. May be assistive in evaluating suspected vasculitis.
• For the workup of suspected vasculitis, the preferred panel is ANCA-Associated Vasculitis Profile (ANCA/MPO/PR-3) with Reflex to ANCA Titer (2006480).

166.
Ordering Recommendation:  

• First-line screening test for ANCA-associated vasculitis.
• A reflex panel is available for the workup of suspected vasculitis; refer to ANCA-Associated Vasculitis Profile (ANCA/MPO/PR-3) Reflex to ANCA Titer (2006480).
• Recommended in the differential evaluation of autoimmune diseases with renal involvement (SLE and anti-glomerular basement membrane disease).
• Recommended adjunct diagnostic tool to differentiate ulcerative colitis from Crohn disease in IBD.

167.
Ordering Recommendation:  

Aids in initial diagnosis of connective tissue disease.

168.
Ordering Recommendation:  

Aids in initial diagnosis of connective tissue disease.

169.
Ordering Recommendation:  

Initial screen for autoimmune connective tissue diseases.

170.
Ordering Recommendation:  

Monitor levels of antimicrobial drug, aztreonam.

171.
Ordering Recommendation:  

Monitor levels of antimicrobial drug, ceftazidime.

172.
Ordering Recommendation:  

Monitor levels of antimicrobial drug, meropenem.

173.
Ordering Recommendation:  

Monitor levels of antimicrobial drug, nafcillin.

174.
Ordering Recommendation:  

Monitor levels of antimicrobial drug, piperacillin.

175.
Ordering Recommendation:  

Monitor levels of antimicrobial drug, ticarcillin.

176.
177.
178.
179.
180.
181.
182.
183.
Ordering Recommendation:  

Monitor levels of antifungal drug, 5-fluorocytosine.

184.
185.
Ordering Recommendation:  

Antigen testing for D, C, E, c, and e to assess maternal, paternal, or newborn Rh phenotype status.

186.
187.
188.
189.
190.
191.
192.
193.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for anaerobic bacterial organisms. Refer to NOTE section below for list of antimicrobial agents available for testing.

194.
Ordering Recommendation:  

Limited data exists to support the use of bactericidal assays in the management of complicated bacterial infections, such as endocarditis and osteomyelitis.

195.
Ordering Recommendation:  

Detect the presence of genes (blaKPC and blaNDM) responsible for resistance to carbapaenem and other beta-lactam antibiotics.

196.
Ordering Recommendation:  

Determine production of carbapenem-inactivating enzymes in gram negative bacterial organisms.

197.
Ordering Recommendation:  

Determine inducible resistance of staphylococci, Streptococcus pneumoniae, and beta-hemolytic streptococci to clindamycin.

198.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for enteric bacterial organisms. Refer to NOTE section below for list of antimicrobial agents available for testing.

199.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for Enterococcus spp. Refer to NOTE section below for list of antimicrobial agents available for testing.

200.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for extended spectrum beta lactamase producing-organisms. Refer to NOTE section below for list of antimicrobial agents available for testing.

201.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for fastidious bacterial organisms. Refer to NOTE section below for list of antimicrobial agents available for testing.

202.
Ordering Recommendation:  

Determine in vitro susceptibility to antifungal agents for fungal organisms. Refer to NOTE for list of antimicrobial agents available for testing.

203.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for gram-positive rod bacterial organisms. Refer to NOTE section below for list of antimicrobial agents available for testing.

204.
Ordering Recommendation:  

Gold standard for detecting oxacillin/nafcillin resistance in Staphylococcus species. Determine presence of mecA gene that confers resistance to nearly all beta-lactam antibiotics. Refer to (0060707) for susceptibility panel testing for Staphylococcus spp.

205.
Ordering Recommendation:  

Determine the minimum inhibitory concentration (MIC) of requested antimicrobial agent against submitted bacterial isolate. Refer to NOTE section below for more information.

206.
Ordering Recommendation:  

Determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of  requested antimicrobial agent against submitted bacterial isolate. Refer to NOTE section below for list of antimicrobial agents available for testing.

207.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for Nocardia spp. and other aerobic actinomycetes. Refer to NOTE section below for specific information.

208.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for nonfermenting gram negative bacterial organisms. Refer to NOTE section below for list of antimicrobial agents available for testing.

209.
Ordering Recommendation:  

Determine in-vitro susceptibility of bacterial organisms to antimicrobial agents. Organism-specific antimicrobial susceptibility tests are recommended. Search “antimicrobial susceptibility” for available organism-specific tests.

210.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for Staphylococcus spp. Refer to NOTE section below for list of antimicrobial agents available for testing. For mecA gene testing, refer to Antimicrobial Susceptibility - mecA Gene by PCR (0060211).

211.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for Streptococcus pneumoniae. Refer to NOTE section below for list of antimicrobial agents available for testing.

212.
Ordering Recommendation:  

Determine in vitro susceptibility to antimicrobial agents for viridans streptococci. Refer to NOTE section below for list of antimicrobial agents available for testing.

213.
Ordering Recommendation:  

Order for SUSCEPTIBILITY of clinically significant isolates of M. tuberculosis complex (MTBC), M. kansasii, M. avium-intracellulare complex, M. fortuitum complex, M. abscessus complex, M. chelonae, M. immunogenum, and any isolate from a significant source.

214.
Ordering Recommendation:  

Order when phenotypic drug susceptibility testing is required for M. tuberculosis treatment. For genotypic (DNA sequencing) resistance testing, refer to Mycobacterium tuberculosis Drug Resistance by Sequencing (2011713).

215.
Ordering Recommendation:  

Blood antimony may be useful for detecting recent exposure.

216.
Ordering Recommendation:  

Preferred initial panel for strong suspicion of antiphospholipid syndrome (APS).

217.
Ordering Recommendation:  

Order to detect and subtype antithrombin deficiency.

218.
Ordering Recommendation:  

Not recommended as an initial test to detect antithrombin (AT) deficiency. Use to determine subtype in AT-deficient individuals.

219.
Ordering Recommendation:  

Recommended test to detect antithrombin deficiency.

220.
Ordering Recommendation:  

Detect herpes simplex virus (HSV) resistance to acyclovir.

221.
Ordering Recommendation:  

Detect herpes simplex virus (HSV) resistance to foscarnet sodium.

222.
Ordering Recommendation:  

This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.

223.
Ordering Recommendation:  

Preferred panel for individuals with clinical phenotype of aortic/vascular aneurysm, dissection, or rupture.

224.
Ordering Recommendation:  

Acceptable panel for individuals with clinical phenotype of aortic/vascular aneurysm, dissection, or rupture.

225.
Ordering Recommendation:  

Acceptable initial test to detect activated protein C resistance due to a factor V Leiden mutation. Preferred test is APC Resistance Profile with Reflex to Factor V Leiden (0030192).  However, Factor V Leiden (F5) R506Q Mutation (0097720) is the preferred initial test for individuals with supratherapeutic concentrations of heparin, direct thrombin inhibitors, extreme factor V deficiency, or lupus anticoagulants with markedly prolonged baseline clotting times.

226.
Ordering Recommendation:  

Recommended test to detect activated protein C resistance and confirm presence of a factor V Leiden mutation.

227.
Ordering Recommendation:  

Not recommended for cardiovascular disease risk assessment. Use to detect the very rare familial alpha-lipoprotein deficiency.

228.
Ordering Recommendation:  

Acceptable non-traditional secondary cardiovascular disease risk screen for specific populations.

229.
Ordering Recommendation:  

Confirm a diagnosis of familial defective Apo B-100 (FDB). Screen individuals with a family history of FDB to assess risk of coronary artery disease.

230.
Ordering Recommendation:  

Not usually recommended for cardiovascular disease risk assessment.

231.
Ordering Recommendation:  

Supports a clinical diagnosis of Alzheimer disease (AD) in symptomatic individuals. Use for AD risk assessment only. Genetic counseling and informed consent are strongly recommended prior to ordering and post-test to discuss results.

232.
Ordering Recommendation:  

Confirm a diagnosis of type III hyperlipoproteinemia for evaluation of premature coronary heart disease.

233.
Ordering Recommendation:  

Aids in evaluation of neuromyelitis optica (NMO) and NMO spectrum disorders.

234.
Ordering Recommendation:  

For evaluation of optic neuritis, acute myelitis, spinal cord lesions, or autoimmune encephalitis.

235.
Ordering Recommendation:  

Useful for initial evaluation of NMO spectrum disorders.

236.
Ordering Recommendation:  

Use in conjunction with serum autoantibody tests to diagnose neuromyelitis optica (NMO).

237.
Ordering Recommendation:  

Aid in the diagnosis of infection with arboviruses in CSF.

238.
Ordering Recommendation:  

Aid in the diagnosis of infection with arboviruses.

239.
Ordering Recommendation:  

Not recommended as a stand-alone test. Refer to arbovirus IgG and IgM antibodies panel for CSF (2001597).

240.
Ordering Recommendation:  

Not recommended as a stand-alone test. Refer to Arbovirus Antibodies, IgG and IgM, Serum (2001594).

241.
Ordering Recommendation:  

Not recommended as a stand-alone test. Refer to Arbovirus Antibodies, IgG and IgM, CSF (2001597).

242.
Ordering Recommendation:  

Not recommended as a stand-alone test. Refer to Arbovirus Antibodies, IgG and IgM, Serum (2001594).

243.
Ordering Recommendation:  

Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.

244.
245.
Ordering Recommendation:  

Preferred molecular genetic test following biochemical testing suggestive of arginine:glycine amidinotransferase (AGAT) deficiency.

246.
Ordering Recommendation:  

Optimize drug therapy and monitor patient adherence.

247.
248.
Ordering Recommendation:  

Refer to Additional Technical Information document.

249.
Ordering Recommendation:  

May be useful in the evaluation of past exposure to arsenic in situations where concern over exposure is high, but urine results are negative. For acute or chronic exposure, Arsenic, Urine with Reflex to Fractionated (0025000) is preferred.

250.
Ordering Recommendation:  

May be useful in the evaluation of past exposure to arsenic in situations where concern over exposure is high, but urine results are negative. For acute or chronic exposure, Arsenic, Urine with Reflex to Fractionated (0025000) is preferred.

251.
Ordering Recommendation:  

May be useful for the detection of recent (<24 hours post exposure) and/or large dose arsenic exposures. For acute or chronic exposure, Arsenic, Urine with Reflex to Fractionated (0025000) is preferred.

252.
Ordering Recommendation:  

Useful when exposure to arsenic is known but the species is uncertain. For initial testing, Arsenic, Urine with Reflex to Fractionated (0025000) is preferred.

253.
Ordering Recommendation:  

Preferred test for the assessment of acute or chronic arsenic exposure. This test is able to differentiate between toxic inorganic and methylated species as well as benign organic forms. Results are reported as total inorganic, total methylated, and organic arsenic.

254.
Ordering Recommendation:  

Preferred test for the assessment of acute or chronic arsenic exposure. This test is able to differentiate between toxic inorganic and methylated species as well as benign organic forms. Results are reported as total inorganic, total methylated, and organic arsenic.

255.
256.
257.
Ordering Recommendation:  

Preferred gene panel for carrier screening in individuals of Ashkenazi Jewish descent.

258.
259.
Ordering Recommendation:  

Not recommended for the diagnosis of invasive aspergillosis. Consider ordering an Aspergillus galactomannan antigen test (serum 0060068 or bronchoscopy 2003150).

260.
Ordering Recommendation:  

Not recommended for the diagnosis of invasive aspergillosis. Consider ordering an Aspergillus galactomannan antigen test (serum 0060068 or bronchoscopy 2003150).

261.
Ordering Recommendation:  

Aspergillus fumigatus-specific IgG is one component of testing recommended to establish the diagnosis of allergic bronchopulmonary aspergillosis (ABPA); it is not appropriate for diagnosing invasive aspergillosis.

262.
263.
264.
Ordering Recommendation:  

Not recommended for the diagnosis of invasive aspergillosis. Consider ordering an Aspergillus galactomannan antigen test (serum 0060068 or bronchoscopy 2003150).

265.
266.
267.
Ordering Recommendation:  

Preferred molecular test for ATP7A-related copper transport disorders.

268.
Ordering Recommendation:  

Acceptable test to confirm diagnosis of Menkes disease, occipital horn syndrome and ATP7A-related distal motor neuropathy; detects most pathogenic ATP7A gene mutations but does not detect deletions and duplications.

269.
Ordering Recommendation:  

This is a second tier test and REQUIRES PERMISSION from ARUP's Genetic Counselor (800-242-2787, x2141) before ordering. Preferred initial test is the sequencing and deletion/duplication test.

270.
Ordering Recommendation:  

Differential evaluation of encephalitis of unknown origin with subacute onset of seizures, confusion, memory loss, and/or behavioral change. For adults and patients with suspicion of cancer, additional evaluation of paraneoplastic autoantibodies is recommended; refer to reflex test (2007961).

271.
Ordering Recommendation:  

Recommended first-line panel for the evaluation of autoimmune liver disease (ALD). Negative results do not rule out disease.

272.
Ordering Recommendation:  

Support the diagnosis of autoimmune lymphoproliferative syndrome (ALPS).

273.
Ordering Recommendation:  

Acceptable reflexive panel for the differential diagnosis of acquired neuromuscular junction disorders. Panel contains binding, blocking, and modulating antibodies; voltage-gated calcium and potassium channels; titin antibody; and striated muscle antibodies.